Skip to content

Test - UgenTec to commercialize FastFinder Assay Plug-in for select Thermo Fisher qPCR respiratory assays 6

Thomas Beuls | Press Release | 15/12/2022

HASSELT, BELGIUM | BOSTON, MA – September 15, 2022

UgenTec today announced a collaborative agreement with Thermo Fisher under which UgenTec will commercialize new CE-IVD marked Assay Plug-ins for the FastFinder software, which is used to analyze and interpret results generated with Thermo Fisher Scientific’s TaqPath COVID-19 CE-IVD RT-PCR kit and the TaqPath™ COVID‑19, Flu A/B, RSV Combo kit.  

Under the agreement, UgenTec, in collaboration with Thermo Fisher, will make  FastFinder available to clinical laboratories to enable a seamless use of the assay and the software. Both organizations validated the Assay Plug-ins under the IVDD Directive (98/79/EC), resulting in a FastFinder Assay Plug-in enabling a regulatory-compliant workflow for routine clinical testing.

FastFinder is designed to enable automated assay result calling through clear, software-based decision rules. It uses data science and artificial intelligence to manage laboratory workflows, track quality metrics and create dashboards. Labs already using the FastFinder software can easily adopt the Assay Plug-in since they have been specifically validated for the TaqPath kits. New FastFinder customers will be able to immediately benefit from a fully traceable workflow – helping to create a full audit trail from sample in to report out.

As COVID-19 testing needs continue to evolve and more laboratories look to test for other respiratory viruses simultaneously, the new Assay Plug-ins will enable the analysis of the results generated with these TaqPath Kits using the same software platform. 

Steven Verhoeven, CEO at UgenTec:

“We’re excited to expand our collaboration with Thermo Fisher. With this next step, we can provide our joint customer labs with a compliant sample-to-result solution that builds on our AI and data science capabilities to help them scale with a compliant solution. Thermo Fisher is the leader in COVID-19 PCR testing – so for us to collaborate and provide those routine clinical labs with intelligent software to build validated, automated testing workflows makes a lot of sense.”

Albert Vilafranca, Vice President,
EMEA Life Sciences Commercial at Thermo Fisher:

“As we have done since the beginning of the pandemic, we remain committed to providing high-quality molecular diagnostic tools to help address the needs of our customers.”

About UgenTec
UgenTec is a leading molecular laboratory software provider servicing molecular diagnostics labs and assay providers globally across clinical, animal, pharma and agbio applications. Its FastFinder software platform is a modular, clinical-grade Software-as-a-Service solution that allows labs of all sizes to standardize and automate their molecular testing workflows. UgenTec’s FastFinder platform applies Artificial Intelligence to automate data analysis and result calling from sample to result, track and trace samples across the lab’s entire assay menu and instrument fleet, and provide the lab with valuable real-time insights in quality and lab operations. FastFinder’s modules include Workflow, Analysis, Insights, QC, Genotyper and Studio. 
For more information, please visit

UgenTec Inc.
Steven Van Vooren, Ph.D.
+1 508 808 5200
Marketing Director

Boston, San Francisco, Stockholm – January 12, 2023